Company

News Releases

Releases are listed in chronological order and are archived by year.  Sign-up to receive news as it is released using the email and RSS tools below.

Archived press releases are made available for informational purposes only.  Press releases may contain certain forward-looking statements that are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.  Archived press releases are current only as of the date of issue and BioPharmX assumes no obligation to update information contained in archived press releases.

 

Archives: Search / 2018 / 2017 / 2016 / 2015 / 2014

2018 Archives

Dec 6, 2018
Nov 16, 2018
Oct 11, 2018
Trial will evaluate 1% concentration of minocycline carried by company's patented HyantX™ delivery system
Sep 28, 2018
Sep 12, 2018
Aug 30, 2018
Aug 14, 2018
Aug 9, 2018
New patent protects improvements in oral drug delivery
Jul 31, 2018
Open-label feasibility study results identify BPX-04 topical minocycline gel, 1% as optimal dose for phase 2 trial
Jul 19, 2018
Waiver eliminates years of additional dermal carcinogenicity studies
Jun 19, 2018
Not satisfied with the pharmaceutical industry's pace of change, BioPharmX picks team of 'best and brightest' experts to identify evolving needs of patients and physicians
Jun 7, 2018
May 24, 2018
For the first time, BioPharmX will share its research at the Congress of Clinical Dermatology
Apr 26, 2018
Mar 20, 2018
Mar 20, 2018
Patent protects a new category of innovative drug delivery systems
Mar 14, 2018
Mar 5, 2018
Jan 26, 2018
Data will be shared at SPIE Photonics West in San Francisco
Jan 12, 2018
Latest product candidate reaffirms growth opportunities for hydrophilic topical delivery system
 

print email rss